Noesis Capital Mangement Corp Has $10.41 Million Stock Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Noesis Capital Mangement Corp decreased its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 209,994 shares of the business services provider’s stock after selling 2,856 shares during the quarter. Stericycle makes up about 2.5% of Noesis Capital Mangement Corp’s holdings, making the stock its 17th biggest position. Noesis Capital Mangement Corp owned approximately 0.23% of Stericycle worth $10,407,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Exchange Traded Concepts LLC lifted its holdings in Stericycle by 87.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock worth $45,000 after purchasing an additional 467 shares during the last quarter. Simplicity Solutions LLC acquired a new stake in shares of Stericycle in the third quarter worth $221,000. Raymond James & Associates lifted its stake in shares of Stericycle by 1.0% in the third quarter. Raymond James & Associates now owns 914,453 shares of the business services provider’s stock worth $40,885,000 after buying an additional 8,781 shares during the last quarter. Stratos Wealth Partners LTD. boosted its holdings in shares of Stericycle by 4.9% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 13,763 shares of the business services provider’s stock worth $615,000 after buying an additional 640 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Stericycle by 17.3% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,078 shares of the business services provider’s stock valued at $808,000 after buying an additional 2,671 shares during the last quarter. Institutional investors own 98.82% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research report on Friday, March 1st. StockNews.com downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Tuesday, April 2nd. Robert W. Baird lowered their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a research note on Friday, April 26th. Truist Financial reduced their price objective on Stericycle from $57.00 to $50.00 and set a “hold” rating for the company in a research report on Monday, April 29th. Finally, Stifel Nicolaus boosted their price objective on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $59.40.

Stericycle Trading Up 3.1 %

SRCL traded up $1.38 during trading on Friday, reaching $46.18. 423,599 shares of the company’s stock were exchanged, compared to its average volume of 506,754. The company’s fifty day moving average price is $50.91 and its 200-day moving average price is $48.25. The firm has a market capitalization of $4.29 billion, a PE ratio of -209.91, a P/E/G ratio of 2.41 and a beta of 1.12. Stericycle, Inc. has a fifty-two week low of $37.78 and a fifty-two week high of $57.06. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The firm had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter last year, the business earned $0.49 earnings per share. The company’s revenue was down 2.8% compared to the same quarter last year. As a group, equities analysts forecast that Stericycle, Inc. will post 2.32 EPS for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.